Breath Analysis to Diagnose Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

April 29, 2024

Study Completion Date

April 29, 2024

Conditions
Lung Cancer
Interventions
DEVICE

Collection of volatile organic compounds during exhalation

"The volatile organic compounds (VOCs) are collected in sorbents at rest and at the end of exhalation according to the concentration of carbon dioxide using ReCIVA breath sampler.~The identification of the VOCs will be done by chromatography (Gas Chromatography Mass Spectrometry GC-MS)"

Trial Locations (7)

59000

Institut Pasteur - Centre de Prévention et d'Education à la Santé (CPES), Lille

Unknown

Hôpital Calmette, CHU, Lille

Hopital Victor Provo, Roubaix

Centre Hospitalier de Saint Quentin, Saint-Quentin

Chu Amiens Salouël, Salouël

Ch Seclin - Seclin, Seclin

Clinique Teissier, Valenciennes

All Listed Sponsors
collaborator

Institut National de Recherche en Informatique et en Automatique

OTHER

collaborator

Institut Pasteur de Lille

OTHER

collaborator

Institut MinesTelecom (IMT)

UNKNOWN

lead

University Hospital, Lille

OTHER

NCT03250390 - Breath Analysis to Diagnose Lung Cancer | Biotech Hunter | Biotech Hunter